JP2022540586A5 - - Google Patents

Info

Publication number
JP2022540586A5
JP2022540586A5 JP2022500799A JP2022500799A JP2022540586A5 JP 2022540586 A5 JP2022540586 A5 JP 2022540586A5 JP 2022500799 A JP2022500799 A JP 2022500799A JP 2022500799 A JP2022500799 A JP 2022500799A JP 2022540586 A5 JP2022540586 A5 JP 2022540586A5
Authority
JP
Japan
Application number
JP2022500799A
Other languages
Japanese (ja)
Other versions
JPWO2021007661A5 (https=
JP2022540586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050967 external-priority patent/WO2021007661A1/en
Publication of JP2022540586A publication Critical patent/JP2022540586A/ja
Publication of JPWO2021007661A5 publication Critical patent/JPWO2021007661A5/ja
Publication of JP2022540586A5 publication Critical patent/JP2022540586A5/ja
Pending legal-status Critical Current

Links

JP2022500799A 2019-07-12 2020-07-10 カンナビノイド誘導体 Pending JP2022540586A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962873692P 2019-07-12 2019-07-12
US62/873,692 2019-07-12
PCT/CA2020/050967 WO2021007661A1 (en) 2019-07-12 2020-07-10 Cannabinoid derivatives

Publications (3)

Publication Number Publication Date
JP2022540586A JP2022540586A (ja) 2022-09-16
JPWO2021007661A5 JPWO2021007661A5 (https=) 2023-07-18
JP2022540586A5 true JP2022540586A5 (https=) 2023-07-18

Family

ID=74209649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022500799A Pending JP2022540586A (ja) 2019-07-12 2020-07-10 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US12195429B2 (https=)
EP (1) EP3997069A4 (https=)
JP (1) JP2022540586A (https=)
WO (1) WO2021007661A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021062559A1 (en) 2019-10-02 2021-04-08 Canopy Growth Corporation Cannabinoid derivatives
EP4065554A4 (en) 2019-11-26 2024-01-10 Canopy Growth Corporation CANNABIGEROL DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MODULATORS
KR20240096817A (ko) 2020-05-19 2024-06-26 사이빈 아이알엘 리미티드 중수소화된 트립타민 유도체 및 사용 방법
US20230192588A1 (en) * 2020-06-03 2023-06-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabidiolic acid (cbda) derivatives and uses thereof
US20240317701A1 (en) 2020-12-17 2024-09-26 Nalu Bio, Inc. Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU766988B2 (en) 1998-04-21 2003-10-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cannabinoids as antioxidants and neuroprotectants
US7612101B2 (en) * 2006-04-24 2009-11-03 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US7968711B2 (en) * 2006-04-24 2011-06-28 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US20120172339A1 (en) * 2009-07-10 2012-07-05 Northeastern University Angiogenic resorcinol derivatives
WO2012011112A1 (en) 2010-07-22 2012-01-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Non psychoactive cannabinoids and uses thereof
US9254272B2 (en) 2011-11-30 2016-02-09 Sutter West Bay Hospitals Resorcinol derivatives
US20180037528A1 (en) * 2015-02-27 2018-02-08 The Feinstein Institute For Medical Research Treatment method, compounds, and method of increasing trpv2 activity
US20210198223A1 (en) * 2017-10-20 2021-07-01 Corbus Pharmaceuticals, Inc. Methods and compositions relating to ultrapure 5-(1,1-dimethylheptyl)-resorcinol
CN112313221A (zh) * 2018-02-13 2021-02-02 比托邦制药有限公司 大麻素衍生物和缀合物以及其用途
WO2019234728A1 (en) 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof
EP3994129A4 (en) 2019-07-04 2023-01-04 Canopy Growth Corporation CANNABINOID DERIVATIVES
JP2022539400A (ja) 2019-07-04 2022-09-08 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021007659A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
US20220259221A1 (en) 2019-07-12 2022-08-18 Canopy Growth Corporation Cannabinoid derivatives
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
EP4038058A4 (en) 2019-10-02 2023-10-25 Canopy Growth Corporation Cannabinoid derivatives
WO2021062559A1 (en) 2019-10-02 2021-04-08 Canopy Growth Corporation Cannabinoid derivatives
EP4065554A4 (en) 2019-11-26 2024-01-10 Canopy Growth Corporation CANNABIGEROL DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MODULATORS
US20230122510A1 (en) 2019-11-26 2023-04-20 Canopy Growth Corporation Cannabinoid derivatives
WO2021113958A1 (en) 2019-12-09 2021-06-17 Canopy Growth Corporation Cannabinoid derivatives
JP2023505517A (ja) 2019-12-09 2023-02-09 キャノピー グロウス コーポレイション カンナビノイド誘導体

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022533484A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)